Physician profile
April E Irons
NPI 1245558410
$1,605.05
in general payments reported to CMS, 2019-2025
24 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $68.24 · 2021: $133 · 2022: $403 · 2023: $200 · 2024: $377 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $323.23 | 2021-2024 | Azstarys |
| Pfizer INC. | $182.52 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $157.87 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $98.91 | 2019-2025 | Gardasil 9, Vaxelis, M-M-R II |
| Tris Pharma INC | $94.99 | 2019-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $89.17 | 2019-2023 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $78.17 | 2019-2021 | |
| Genentech USA, INC. | $67.32 | 2019-2023 | Xofluza |
| Kaleo, INC. | $64.73 | 2022-2023 | Auvi-Q |
| Sobi, INC | $59.95 | 2019-2023 | |
| Neos Therapeutics, LP | $58.75 | 2019-2020 | |
| Sanofi Pasteur INC. | $45.88 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $43.68 | 2024-2025 | |
| Noven Therapeutics, LLC | $37.21 | 2024 | Xelstrym |
| Hologic Sales and Service, LLC | $34.08 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $24.39 | 2022 | |
| Seqirus USA INC | $24.24 | 2023 | Flucelvax Quadrivalent |
| Verrica Pharmaceuticals INC. | $22.00 | 2024 | Ycanth |
| Insulet Corporation | $19.10 | 2019 | |
| Zealand Pharma US, INC. | $17.99 | 2022 | |
| Collegium Pharmaceutical, INC. | $16.03 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $15.01 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.97 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Irons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.